Published in Gastroenterology on October 29, 2008
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11
Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature (2010) 5.81
Stem cells and liver regeneration. Gastroenterology (2009) 3.40
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature (2014) 2.23
Studying and modelling dynamic biological processes using time-series gene expression data. Nat Rev Genet (2012) 2.01
Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell (2012) 1.94
Impulse control: temporal dynamics in gene transcription. Cell (2011) 1.79
Therapeutic liver reconstitution with murine cells isolated long after death. Gastroenterology (2010) 1.78
Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells. J Hepatol (2015) 1.74
Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol (2011) 1.69
Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction. Mol Ther (2011) 1.61
A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods (2011) 1.60
New concepts in liver regeneration. J Gastroenterol Hepatol (2011) 1.55
Methanobactin reverses acute liver failure in a rat model of Wilson disease. J Clin Invest (2016) 1.52
HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development (2011) 1.50
Adipose tissue-derived mesenchymal stem cell-based liver gene delivery. J Hepatol (2010) 1.50
Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol (2012) 1.46
Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41
Vertebrate intestinal endoderm development. Dev Dyn (2011) 1.41
Derivation and characterization of hepatic progenitor cells from human embryonic stem cells. PLoS One (2009) 1.33
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv (2014) 1.33
New perspectives in human stem cell therapeutic research. BMC Med (2009) 1.33
Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development (2013) 1.23
Stem cells in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol (2009) 1.23
Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest (2012) 1.22
Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology (2012) 1.21
Current status of pluripotent stem cells: moving the first therapies to the clinic. Nat Rev Drug Discov (2015) 1.18
Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol (2009) 1.17
Differentiation of hepatocytes from pluripotent stem cells. Curr Protoc Stem Cell Biol (2013) 1.14
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med (2013) 1.07
Cell delivery: from cell transplantation to organ engineering. Cell Transplant (2010) 1.06
Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells. Stem Cells Transl Med (2013) 1.06
An endothelial cell niche induces hepatic specification through dual repression of Wnt and Notch signaling. Stem Cells (2011) 1.03
Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol (2014) 1.03
Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies. Stem Cell Res (2012) 1.00
Hepatic differentiation of amniotic epithelial cells. Hepatology (2011) 0.99
Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells. PLoS One (2010) 0.99
Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? Br J Clin Pharmacol (2013) 0.98
Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. J Clin Invest (2014) 0.97
New approaches in the differentiation of human embryonic stem cells and induced pluripotent stem cells toward hepatocytes. Stem Cell Rev (2011) 0.97
Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes. Stem Cell Reports (2015) 0.95
Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res (2010) 0.94
Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells. Int J Biochem Cell Biol (2010) 0.94
Engineering of an hepatic organoid to develop liver assist devices. Cell Transplant (2010) 0.93
Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers. Mol Cell Endocrinol (2011) 0.93
Directing lung endoderm differentiation in pluripotent stem cells. Cell Stem Cell (2012) 0.92
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype. PLoS One (2012) 0.92
Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells. Stem Cell Reports (2015) 0.91
An in vitro expansion system for generation of human iPS cell-derived hepatic progenitor-like cells exhibiting a bipotent differentiation potential. PLoS One (2013) 0.91
Potentials of regenerative medicine for liver disease. Surg Today (2009) 0.90
Human pluripotent stem cells for modelling human liver diseases and cell therapy. Curr Gene Ther (2013) 0.90
Current Bioengineering Methods for Whole Kidney Regeneration. Stem Cells Int (2015) 0.89
Thinking outside the liver: induced pluripotent stem cells for hepatic applications. World J Gastroenterol (2013) 0.88
Stem cells and stem cell-derived tissues and their use in safety assessment. J Biol Chem (2013) 0.88
Factors from human embryonic stem cell-derived fibroblast-like cells promote topology-dependent hepatic differentiation in primate embryonic and induced pluripotent stem cells. J Biol Chem (2010) 0.88
Hepatic targeting and biodistribution of human fetal liver stem/progenitor cells and adult hepatocytes in mice. Hepatology (2009) 0.88
Efficient large-scale generation of functional hepatocytes from mouse embryonic stem cells grown in a rotating bioreactor with exogenous growth factors and hormones. Stem Cell Res Ther (2013) 0.87
Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice. Am J Pathol (2013) 0.87
Stem cells for liver repopulation. Curr Opin Organ Transplant (2009) 0.86
Cellular therapy and bioartificial approaches to liver replacement. Curr Opin Organ Transplant (2012) 0.86
Analysis of alternative signaling pathways of endoderm induction of human embryonic stem cells identifies context specific differences. BMC Syst Biol (2012) 0.86
The potential of stem cells for the restoration of auditory function in humans. Regen Med (2013) 0.85
Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes. Cell Res (2016) 0.84
Amelioration of Hyperbilirubinemia in Gunn Rats after Transplantation of Human Induced Pluripotent Stem Cell-Derived Hepatocytes. Stem Cell Reports (2015) 0.84
An implantable vascularized protein gel construct that supports human fetal hepatoblast survival and infection by hepatitis C virus in mice. PLoS One (2010) 0.83
A gutsy task: generating intestinal tissue from human pluripotent stem cells. Dig Dis Sci (2013) 0.83
Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction. J Biomed Biotechnol (2010) 0.83
Assembly of human organs from stem cells to study liver disease. Am J Pathol (2013) 0.83
Comparison of hepatic-like cell production from human embryonic stem cells and adult liver progenitor cells: CAR transduction activates a battery of detoxification genes. Stem Cell Rev (2011) 0.83
Mapping the Cell-Surface N-Glycoproteome of Human Hepatocytes Reveals Markers for Selecting a Homogeneous Population of iPSC-Derived Hepatocytes. Stem Cell Reports (2016) 0.83
Differentiation and selection of hepatocyte precursors in suspension spheroid culture of transgenic murine embryonic stem cells. PLoS One (2012) 0.82
Generation of functional hepatic cells from pluripotent stem cells. J Stem Cell Res Ther (2012) 0.82
Activins and follistatins: Emerging roles in liver physiology and cancer. World J Hepatol (2009) 0.82
Endothelial cell co-culture mediates maturation of human embryonic stem cell to pancreatic insulin producing cells in a directed differentiation approach. J Vis Exp (2012) 0.82
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes. J Hepatol (2016) 0.82
Enhanced differentiation of adult bone marrow-derived stem cells to liver lineage in aggregate culture. Tissue Eng Part A (2011) 0.81
Spheroid Formation and Evaluation of Hepatic Cells in a Three-Dimensional Culture Device. Cell Med (2015) 0.81
Murine embryonic stem cell-derived hepatocytes correct metabolic liver disease after serial liver repopulation. Int J Biochem Cell Biol (2012) 0.80
Cell transplantation to replace whole liver transplantation. Gastroenterology (2009) 0.80
Modeling human liver biology using stem cell-derived hepatocytes. Int J Mol Sci (2013) 0.80
Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency. Hepatology (2015) 0.80
Assessing the therapeutic potential of lab-made hepatocytes. Hepatology (2016) 0.80
De novo kidney regeneration with stem cells. J Biomed Biotechnol (2012) 0.80
Whole-organ re-engineering: a regenerative medicine approach to digestive organ replacement. Surg Today (2012) 0.79
Differences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary Hepatocytes. PLoS One (2015) 0.79
Stem cell differentiation and human liver disease. World J Gastroenterol (2012) 0.79
Engraftment potential of spheroid-forming hepatic endoderm derived from human embryonic stem cells. Stem Cells Dev (2013) 0.79
From skin cells to hepatocytes: advances in application of iPS cell technology. J Clin Invest (2010) 0.79
The road to regenerative liver therapies: the triumphs, trials and tribulations. Biotechnol Adv (2013) 0.78
Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen. Stem Cell Res (2016) 0.78
Low oxygen tension enhances the generation of lung progenitor cells from mouse embryonic and induced pluripotent stem cells. Physiol Rep (2014) 0.78
Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing. Toxicol Sci (2014) 0.78
New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases. Curr Transplant Rep (2015) 0.77
Embryonic and induced pluripotent stem cells as a model for liver disease. Crit Rev Biomed Eng (2009) 0.77
Activin A maintains pluripotency markers and proliferative potential of human induced pluripotent stem cells. Exp Ther Med (2011) 0.77
The human constitutive androstane receptor promotes the differentiation and maturation of hepatic-like cells. Dev Biol (2013) 0.77
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol (2006) 10.95
Hepatitis C virus replication in mice with chimeric human livers. Nat Med (2001) 5.87
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol (2007) 5.04
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology (2005) 3.72
Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology (2007) 3.29
Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A (2008) 2.99
Stem cell characteristics of amniotic epithelial cells. Stem Cells (2005) 2.66
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology (2007) 2.40
The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech (2003) 2.30
Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol (2006) 2.21
The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev (1995) 2.07
Albumin-deficient rat mutant. Science (1979) 1.83
Embryonic stem cells as a source of models for drug discovery. Nat Rev Drug Discov (2007) 1.82
Use of human hepatocytes to study P450 gene induction. Methods Enzymol (1996) 1.79
Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci U S A (1995) 1.65
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Purification and properties of human coagulation factor VII. J Biol Chem (1980) 1.61
Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation (2004) 1.53
Hepatocyte transplantation. J Hepatol (2004) 1.50
Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride. Transplantation (2002) 1.48
Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc (1977) 1.35
The use of human hepatocyte cultures to study the induction of cytochrome P-450. Drug Metab Dispos (1999) 1.30
Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology (2006) 1.27
Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology (2005) 1.26
Bioluminescent monitoring of islet graft survival after transplantation. Mol Ther (2004) 1.21
Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev (2005) 1.16
Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells. Biochem Pharmacol (2007) 1.08
Effects of bergamottin on human and monkey drug-metabolizing enzymes in primary cultured hepatocytes. Drug Metab Dispos (2002) 1.04
Purification and characterization of tissue factor apoprotein. Methods Enzymol (1976) 1.00
In vitro transdifferentiation of adult hematopoietic stem cells: an alternative source of engraftable hepatocytes. J Hepatol (2008) 1.00
Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coagul Fibrinolysis (1996) 0.96
Susceptibility of chimeric mice with livers repopulated by serially subcultured human hepatocytes to hepatitis B virus. Hepatology (2008) 0.91
Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant (2002) 0.86
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65
Mapping the genetic architecture of gene expression in human liver. PLoS Biol (2008) 19.44
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol (2005) 18.32
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 17.57
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol (2002) 13.10
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature (2011) 11.59
Sequencing of 50 human exomes reveals adaptation to high altitude. Science (2010) 11.27
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004) 9.40
Cell type-specific involvement of RIG-I in antiviral response. Immunity (2005) 9.37
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol (2005) 7.94
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11
Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol (2002) 7.07
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab (2005) 6.85
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature (2011) 6.21
Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol (2004) 5.71
Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol (2002) 5.48
Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol (2008) 5.10
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol (2007) 5.04
Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med (2006) 5.01
The extracellular matrix guides the orientation of the cell division axis. Nat Cell Biol (2005) 5.00
TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol (2003) 4.94
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature (2002) 4.81
Asthma control during the year after bronchial thermoplasty. N Engl J Med (2007) 4.79
The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med (2004) 4.14
Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat Immunol (2006) 4.01
Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med (2005) 3.85
Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation (2013) 3.57
Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol (2008) 3.55
Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells (2007) 3.39
SOCS-1 participates in negative regulation of LPS responses. Immunity (2002) 3.39
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol (2002) 3.32
Coherent emission of light by thermal sources. Nature (2002) 3.29
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature (2004) 3.19
Anisotropy of cell adhesive microenvironment governs cell internal organization and orientation of polarity. Proc Natl Acad Sci U S A (2006) 3.15
Human hepatocyte transplantation: worldwide results. Transplantation (2006) 3.02
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med (2005) 2.90
LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A (2010) 2.90
Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med (2009) 2.88
MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy (2012) 2.87
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol (2011) 2.75
A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates. N Engl J Med (2015) 2.73
Stem cell characteristics of amniotic epithelial cells. Stem Cells (2005) 2.66
Cell distribution of stress fibres in response to the geometry of the adhesive environment. Cell Motil Cytoskeleton (2006) 2.63
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol (2006) 2.57
Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant (2010) 2.50
The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol (2008) 2.48
Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One (2010) 2.44
Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity (2010) 2.32
Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood (2008) 2.26
Panhematin provides a therapeutic benefit in experimental pancreatitis. Gut (2010) 2.23
Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol (2006) 2.21
TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem (2006) 2.19
Bronchial thermoplasty for asthma. Am J Respir Crit Care Med (2006) 2.15
A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol (2005) 2.12
TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. J Clin Invest (2012) 2.10
Toll-like receptors and their signaling mechanisms. Scand J Infect Dis (2003) 2.08
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res (2010) 2.06
Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology (2006) 2.04
A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med (2004) 2.01
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Similar electrophysiological changes in axotomized and neighboring intact dorsal root ganglion neurons. J Neurophysiol (2002) 1.93
Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med (2004) 1.92
Diabetes and poor outcomes within 6 months after acute ischemic stroke: the China National Stroke Registry. Stroke (2011) 1.91
The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke (2011) 1.90
Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: assay development for total salivary pepsin/pepsinogen. Clin Chem (2010) 1.87
Biological implications of cell fusion. Nat Rev Mol Cell Biol (2005) 1.87
Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant (2003) 1.86
Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol Cell (2009) 1.84
West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis (2004) 1.84
Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood (2009) 1.81
Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles (2012) 1.81
Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues. Bioorg Med Chem Lett (2005) 1.79
Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science (2010) 1.77
Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat Struct Mol Biol (2008) 1.71
Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1. J Mol Med (Berl) (2002) 1.70
Heme oxygenase-1 deficiency leads to disrupted response to acute stress in stem cells and progenitors. Blood (2008) 1.70
Narrowing candidate region for monosomy 9p syndrome to a 4.7-Mb segment at 9p22.2-p23. Am J Med Genet A (2006) 1.70
Structural basis of selective ubiquitination of TRF1 by SCFFbx4. Dev Cell (2010) 1.68
Activation of DegP chaperone-protease via formation of large cage-like oligomers upon binding to substrate proteins. Proc Natl Acad Sci U S A (2008) 1.68
Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci U S A (2010) 1.67
Pathological role of Toll-like receptor signaling in cerebral malaria. Int Immunol (2006) 1.66
Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice. J Hepatol (2009) 1.64
Genotyping of three candidate genes after whole-genome preamplification of DNA collected from buccal cells. Behav Genet (2003) 1.64
Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance. J Mol Cell Cardiol (2008) 1.63
Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev (2009) 1.62
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol (2004) 1.62
Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2). Bioorg Med Chem Lett (2005) 1.60
Cutting Edge: Pivotal function of Ubc13 in thymocyte TCR signaling. J Immunol (2006) 1.60
A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods (2011) 1.60